Vincent Zecchini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vincent Zecchini has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
A. Ramos-Montoya
1 shared publicationAlyson Speed
Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK
1 shared publication- Ana Sofia Henriques da Costa
Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK
1 shared publication Ashley Ferguson
Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK
1 shared publication- Christian Frezza
Faculty of Medicine and University Hospital Cologne, Institute for Metabolomics in Ageing, Cologne Excellence Cluster on Cellular Stress Responses in Ageing-Associated Diseases (CECAD), University of Cologne, 50931 Cologne, Germany
1 shared publication - David Edgar Neal
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 8 March 2023
- Published by Springer Nature in Nature
- Vol. 615 (7952) , 499-506
Fumarate induces vesicular release of mtDNA to drive innate immunity
Mutations in fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma1. Loss of FH in the kidney elicits several oncogenic signalling cascades through the accumulation of the oncometabolite fumarate2. However, although the long-term consequences of FH loss have been described, the acute response has not so far been investigated. Here we generated an inducible mouse model to study the chronology of FH loss in the kidney. We show that loss of FH leads to early alterations of mitochondrial morphology and the release of mitochondrial DNA (mtDNA) into the cytosol, where it triggers the activation of the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING)–TANK-binding kinase 1 (TBK1) pathway and stimulates an inflammatory response that is also partially dependent on retinoic-acid-inducible gene I (RIG-I). Mechanistically, we show that this phenotype is mediated by fumarate and occurs selectively through mitochondrial-derived vesicles in a manner that depends on sorting nexin 9 (SNX9). These results reveal that increased levels of intracellular fumarate induce a remodelling of the mitochondrial network and the generation of mitochondrial-derived vesicles, which allows the release of mtDNAin the cytosol and subsequent activation of the innate immune response.
- 8 March 2023
- Published by Springer Nature in Nature
- Vol. 615 (7952) , 499-506
Top Cited PapersOpen AccessFumarate induces vesicular release of mtDNA to drive innate immunity
Mutations in fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma1. Loss of FH in the kidney elicits several oncogenic signalling cascades through the accumulation of the oncometabolite fumarate2. However, although the long-term consequences of FH loss have been described, the acute response has not so far been investigated. Here we generated an inducible mouse model to study the chronology of FH loss in the kidney. We show that loss of FH leads to early alterations of mitochondrial morphology and the release of mitochondrial DNA (mtDNA) into the cytosol, where it triggers the activation of the cyclic GMP–AMP synthase (cGAS)–stimulator of interferon genes (STING)–TANK-binding kinase 1 (TBK1) pathway and stimulates an inflammatory response that is also partially dependent on retinoic-acid-inducible gene I (RIG-I). Mechanistically, we show that this phenotype is mediated by fumarate and occurs selectively through mitochondrial-derived vesicles in a manner that depends on sorting nexin 9 (SNX9). These results reveal that increased levels of intracellular fumarate induce a remodelling of the mitochondrial network and the generation of mitochondrial-derived vesicles, which allows the release of mtDNAin the cytosol and subsequent activation of the innate immune response.
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e283
283 Similar expression to FGF (Sef) is an important determinant of the prostate cancer cells' ability to metastasise in vivo
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e283
283 Similar expression to FGF (Sef) is an important determinant of the prostate cancer cells' ability to metastasise in vivo
- 9 February 2009
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 107 (1) , 19-29
Putting chromatin immunoprecipitation into context
Chromatin immunoprecipitation (ChIP), when paired with sequencing or arrays, has become a method of choice for the unbiased identification of genomic‐binding sites for transcription factors and epigenetic marks in various model systems. The data generated is often then interpreted by groups seeking to link these binding sites to the expression of adjacent or distal genes, and more broadly to the evolution of species, cell fate/differentiation or even cancer development. Against this backdrop is an ongoing debate over the relative importance DNA sequence versus chromatin structure and modification in the regulation of gene expression (Anon. 2008a Nature 454: 795; Anon. 2008b Nature 454: 711–715; Henikoff et al. 2008 Science 322: 853; Madhani et al. 2008 Science 322: 43–44). Rationally there is a synergy between the two and the goal of a biologist is to characterise both comprehensively enough to explain a cellular phenotype or a developmental process. If this is truly our goal then the critical factor in good science is an awareness of the constraints and potential of the biological models used. The reality however is often that this discussion is polarised by funding imperatives and the need to align to a transcription factor or epigenetic camp. This article will discuss the extrapolations involved in using ChIP data to draw conclusions about these themes and the discoveries that have resulted. J. Cell. Biochem. 107: 19–29, 2009.
- 9 February 2009
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 107 (1) , 19-29
Putting chromatin immunoprecipitation into context
Chromatin immunoprecipitation (ChIP), when paired with sequencing or arrays, has become a method of choice for the unbiased identification of genomic‐binding sites for transcription factors and epigenetic marks in various model systems. The data generated is often then interpreted by groups seeking to link these binding sites to the expression of adjacent or distal genes, and more broadly to the evolution of species, cell fate/differentiation or even cancer development. Against this backdrop is an ongoing debate over the relative importance DNA sequence versus chromatin structure and modification in the regulation of gene expression (Anon. 2008a Nature 454: 795; Anon. 2008b Nature 454: 711–715; Henikoff et al. 2008 Science 322: 853; Madhani et al. 2008 Science 322: 43–44). Rationally there is a synergy between the two and the goal of a biologist is to characterise both comprehensively enough to explain a cellular phenotype or a developmental process. If this is truly our goal then the critical factor in good science is an awareness of the constraints and potential of the biological models used. The reality however is often that this discussion is polarised by funding imperatives and the need to align to a transcription factor or epigenetic camp. This article will discuss the extrapolations involved in using ChIP data to draw conclusions about these themes and the discoveries that have resulted. J. Cell. Biochem. 107: 19–29, 2009.